BDBM508622 (R or S)-8-[2-(6,6-difluoro-2- azabicyclo[2.2.1]hept-2-yl)ethyl]-2,2- difluoro[1,3]dioxolo[4,5-h][1,2,4] triazolo[1,5-c]quinazolin-5-amine (faster eluting b)::US11046714, Example 66::US11046714, Example 67

SMILES Nc1nc2c3OC(F)(F)Oc3ccc2c2nc(CCN3CC4CC3C(F)(F)C4)nn12

InChI Key InChIKey=KHYQDCRSZOBGGT-UHFFFAOYSA-N

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 508622   

TargetAdenosine receptor A2a(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM508622((R or S)-8-[2-(6,6-difluoro-2- azabicyclo[2.2.1]he...)
Affinity DataKi:  3nMAssay Description:The following table shows representative data for the compounds of the Examples as A2a receptor antagonists as determined by a competition binding as...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM508622((R or S)-8-[2-(6,6-difluoro-2- azabicyclo[2.2.1]he...)
Affinity DataKi:  3.5nMAssay Description:The following table shows representative data for the compounds of the Examples as A2a receptor antagonists as determined by a competition binding as...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent